Drugs / Zhilong Huoxue Tongyu capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06709638 | Feb → Dec 2024 | coronary artery disorder | Jiang Hanmei | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Zhilong Huoxue Tongyu capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06709638 ↗ |